<p><strong>Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis</strong>: 40 mg every other week Some patients with RA not receiving methotrexate may benefit from increasing the frequency to 40 mg every week.<br />
<br />
Juvenile Idiopathic Arthritis:</p>

<ul>
	<li><strong>10 kg to &lt;15 kg</strong>: 10 mg every other week</li>
	<li><strong>15 kg to &lt; 30 kg</strong>: 20 mg every other week</li>
	<li><strong>&ge; 30 kg</strong>: 40 mg every other week</li>
</ul>

<p>Adult Crohn&#39;s Disease and Ulcerative Colitis:</p>

<ul>
	<li><strong>Initial dose (Day 1)</strong>: 160 mg (four 40 mg injections in one day or two 40 mg injections per day for two consecutive days).</li>
	<li><strong>Second dose two weeks later (Day 15)</strong>: 80 mg.</li>
	<li><strong>Two weeks later (Day 29)</strong>: Maintenance dose of 40 mg every other week.</li>
	<li><strong>For patients with Ulcerative Colitis only</strong>: Adalimumab should only be continued in patients who have shown evidence of clinical remission by eight weeks (Day 57) of therapy.</li>
</ul>

<p>Pediatric Crohn&rsquo;s Disease:</p>

<ul>
	<li><strong>17 kg to &lt; 40 kg</strong>: Initial dose (Day 1): 80 mg (two 40 mg injections in one day) , Second dose two weeks later (Day 15): 40 mg , Two weeks later (Day 29): Maintenance dose of 20 mg every other week.</li>
	<li><strong>&ge; 40 kg</strong>: Initial dose (Day 1): 160 mg (four 40 mg injections in one day or two 40 mg injections per day for two consecutive days) , Second dose two weeks later (Day 15): 80 mg (two 40 mg injections in one day) , Two weeks later (Day 29): Maintenance dose of 40 mg every other week.</li>
</ul>

<p>Plaque Psoriasis:</p>

<ul>
	<li>80 mg initial dose, followed by 40 mg every other week starting one week after initial dose.</li>
	<li><strong>Hidradenitis Suppurativa</strong>: Initial dose (Day 1): 160 mg (given as four 40 mg injection on Day 1 or as two 40 mg injections per day on Days 1 and 2, Second dose two weeks later (Day 15): 80 mg (two 40 mg injections in one day), Third (Day 29) and subsequent doses: 40 mg every week.</li>
</ul>

<p><strong>Administration : Administered by subcutaneous injection.</strong></p>